Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5α and Escherichia coli K1 strains by murine microglial cells

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 557-564

  Ribes, Sandra ^a   Ebert, Sandra ^a   Czesnik, Dirk ^a   Regen, Tommy ^a   Zeug, Andre ^a   Bukowski, Stephanie ^a   Mildner, Alexander ^b   Eiffert, Helmut ^a   Hanisch, Uwe Karsten ^a   Hammerschmidt, Sven ^c   Nau, Roland ^a,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Sleep Laboratory   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CXCL1 CHEMOKINE; CYTOCHALASIN D; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TRIPALMITOYL S GLYCERYLCYSTEINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; MICROGLIA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 58449119213     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00903-08     Document Type: Article

References (32)

1. Aravalli, R. N., P. K. Peterson, and J. R. Lokensgard. 2007. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimmune Pharmacol. 2:297-312.
2. Armstrong, D. 1984. Central nervous system infections in the immunocompromised host. Infection 12(Suppl. 1):S58-S64.
3. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-1018.
4. Dalpke, A. H., M. Frey, S. Morath, T. Hartung, and K. Heeg. 2002. Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells. Immunobiology 206:392-407.
5. Daubenberger, C. A. 2007. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines. Curr. Opin. Mol. Ther. 9:45-52.
6. Doyle, S. E., R. M. O'Connell, G. A. Miranda, S. A. Vaidya, E. K. Chow, P. T. Liu, S. Suzuki, N. Suzuki, R. L. Modlin, W. C. Yeh, T. F. Lane, and G. Cheng. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199:81-90.
7. Ebert, S., J. Gerber, S. Bader, F. Muhlhauser, K. Brechtel, T. J. Mitchell, and R. Nau. 2005. Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J. Neuroimmunol. 159:87-96.
8. Fexby, S., T. Bjarnsholt, P. O. Jensen, V. Roos, N. Hoiby, M. Givskov, and P. Klemm. 2007. Biological Trojan horse: antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect. Immun. 75:30-34.
9. Hanisch, U. K. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
10. Hanisch, U. K., and H. Kettenmann. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10:1387-1394.
11. Harris, T. H., J. M. Mansfield, and D. M. Paulnock. 2007. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect. Immun. 75:2366-2373.
12. Häusler, K. G., M. Prinz, C. Nolte, J. R. Weber, R. R. Schumann, H. Kettenmann, and U. K. Hanisch. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide-and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16:2113-2122.
13. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
14. Jones, B. W., T. K. Means, K. A. Heldwein, M. A. Keen, P. J. Hill, J. T. Belisle, and M. J. Fenton. 2001. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 69:1036-1044.
15. Laflamme, N., and S. Rivest. 1999. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor κB alpha within specific cellular populations of the rat brain. J. Neurochem. 73:309-321.
16. Lemstra, A. W., J. C. Groen in't Woud, J. J. Hoozemans, E. S. van Haastert, A. J. Rozemuller, P. Eikelenboom, and W. A. van Gool. 2007. Microglia activation in sepsis: a case-control study. J. Neuroinflammation 4:4.
17. Lotz, M., S. Ebert, H. Esselmann, A. I. Iliev, M. Prinz, N. Wiazewicz, J. Wiltfang, J. Gerber, and R. Nau. 2005. Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. J. Neurochem. 94:289-298.
18. Mae, M., M. Iyori, M. Yasuda, H. M. Shamsul, H. Kataoka, K. Kiura, A. Hasebe, Y. Totsuka, and K. Shibata. 2007. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway. FEMS Immunol. Med. Microbiol. 49:398-409.
19. Nazareth, H., S. A. Genagon, and T. A. Russo. 2007. Extraintestinal pathogenic Escherichia coli survives within neutrophils. Infect. Immun. 75:2776-2785.
20. Neal, M. D., C. Leaphart, R. Levy, J. Prince, T. R. Billiar, S. Watkins, J. Li, S. Cetin, H. Ford, A. Schreiber, and D. J. Hackam. 2006. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 176:3070-3079.
21. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
22. Roach, J. C., G. Glusman, L. Rowen, A. Kaur, M. K. Purcell, K. D. Smith, L. E. Hood, and A. Aderem. 2005. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 102:9577-9582.
23. Russo, T. A., and J. R. Johnson. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
24. Russo, T. A., and J. R. Johnson. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754.
25. Segura, M. A., P. Cleroux, and M. Gottschalk. 1998. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol. Med. Microbiol. 21:189-195.
26. Silver, R. P., W. Aaronson, and W. F. Vann. 1988. The K1 capsular polysaccharide of Escherichia coli. Rev. Infect. Dis. 10(Suppl. 2):S282-S286.
27. Simard, A. R., and S. Rivest. 2005. Do pathogen exposure and innate immunity cause brain diseases? Neurol. Res. 27:717-725.
28. Smith, M. E., K. van der Maesen, and F. P. Somera. 1998. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production. J. Neurosci. Res. 54:68-78.
29. Sorensen, M., C. Lippuner, T. Kaiser, A. Misslitz, T. Aebischer, and D. Bumann. 2003. Rapidly maturing red fluorescent protein variants with strongly enhanced brightness in bacteria. FEBS Lett. 552:110-114.
30. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
31. Tyring, S. K., I. I. Arany, M. A. Stanley, M. H. Stoler, M. A. Tomai, R. L. Miller, M. L. Owens, and M. H. Smith. 1998. Mechanism of action of imiquimod 5% cream in the treatment of anogenital warts. Prim. Care Update Ob. Gyns. 5:151-152.
32. Xu, J., and E. A. Ling. 1994. Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide. J. Anat. 184:285-296.